| Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality D Costa, B Simbrunner, M Jachs, L Hartl, D Bauer, R Paternostro, ... Journal of Hepatology 74 (4), 819-828, 2021 | 124 | 2021 |
| Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity M Mandorfer, P Schwabl, R Paternostro, K Pomej, D Bauer, J Thaler, C Ay, ... Alimentary pharmacology & therapeutics 47 (7), 980-988, 2018 | 95 | 2018 |
| HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease G Semmler, EL Meyer, K Kozbial, P Schwabl, S Hametner-Schreil, ... Journal of hepatology 76 (4), 812-821, 2022 | 85 | 2022 |
| Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease B Scheiner, G Semmler, F Maurer, P Schwabl, TA Bucsics, R Paternostro, ... Liver International 40 (1), 194-204, 2020 | 73 | 2020 |
| The value of different CT‐based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis R Paternostro, K Lampichler, C Bardach, U Asenbaum, C Landler, ... Liver International 39 (12), 2374-2385, 2019 | 66 | 2019 |
| Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes M Jachs, L Hartl, D Schaufler, C Desbalmes, B Simbrunner, E Eigenbauer, ... Gut 70 (9), 1758-1767, 2021 | 61 | 2021 |
| Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease J Trebicka, W Gu, V de Ledinghen, C Aubé, A Krag, M Praktiknjo, ... Gut 71 (2), 402-414, 2022 | 59 | 2022 |
| Noninvasive risk stratification after HCV eradication in patients with advanced chronic liver disease G Semmler, T Binter, K Kozbial, P Schwabl, S Hametner‐Schreil, ... Hepatology 73 (4), 1275-1289, 2021 | 59 | 2021 |
| Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease L Hartl, K Haslinger, M Angerer, G Semmler, M Schneeweiss‐Gleixner, ... Hepatology 76 (6), 1563-1575, 2022 | 58 | 2022 |
| Clinical course of porto-sinusoidal vascular disease is distinct from idiopathic noncirrhotic portal hypertension K Wöran, G Semmler, M Jachs, B Simbrunner, DJM Bauer, T Binter, ... Clinical Gastroenterology and Hepatology 20 (2), e251-e266, 2022 | 54 | 2022 |
| Safety of direct oral anticoagulants in patients with advanced liver disease G Semmler, K Pomej, DJM Bauer, L Balcar, B Simbrunner, T Binter, ... Liver International 41 (9), 2159-2170, 2021 | 47 | 2021 |
| Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis BS Hofer, B Simbrunner, L Hartl, M Jachs, DJM Bauer, L Balcar, ... Clinical Gastroenterology and Hepatology 21 (9), 2308-2317. e7, 2023 | 46 | 2023 |
| The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats P Schwabl, K Brusilovskaya, P Supper, D Bauer, P Königshofer, F Riedl, ... Scientific Reports 8 (1), 9372, 2018 | 45 | 2018 |
| Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, L Balcar, B Hofer, ... Clinical Gastroenterology and Hepatology 21 (9), 2318-2326. e7, 2023 | 44 | 2023 |
| Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, B Scheiner, ... Clinical Gastroenterology and Hepatology 20 (6), 1362-1373. e6, 2022 | 42 | 2022 |
| Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis G Semmler, K Wöran, B Scheiner, LW Unger, R Paternostro, J Stift, ... United European gastroenterology journal 8 (3), 321-331, 2020 | 41 | 2020 |
| Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD B Scheiner, L Balcar, RJ Nussbaumer, J Weinzierl, R Paternostro, ... Journal of hepatology 76 (5), 1090-1099, 2022 | 40 | 2022 |
| Predicting vaginal delivery in nulliparous women undergoing induction of labor at term T Kawakita, UM Reddy, CC Huang, TC Auguste, D Bauer, RT Overcash American journal of perinatology 35 (07), 660-668, 2018 | 40 | 2018 |
| The sequential application of Baveno VII criteria and VITRO score improves diagnosis of clinically significant portal hypertension M Jachs, L Hartl, B Simbrunner, D Bauer, R Paternostro, B Scheiner, ... Clinical Gastroenterology and Hepatology 21 (7), 1854-1863. e10, 2023 | 38 | 2023 |
| Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice T Bucsics, M Schoder, N Goeschl, P Schwabl, M Mandorfer, M Diermayr, ... Digestive and Liver Disease 49 (12), 1360-1367, 2017 | 38 | 2017 |
Mattias MandorferMedical University of Vienna在 meduniwien.ac.at 的电子邮件经过验证
